NASDAQ

Intensity Therapeutics, Inc. (INTS)

♥ 542 Thanks from members

Live price chart, market sentiment, and community perspectives for Intensity Therapeutics, Inc. (NASDAQ: INTS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Ouldan HouchenFounder: Dr. Saied MirshahidiLeadership: Dr. Ouldan Houchen (CEO)Leadership: Chief Medical OfficerHolder: Institutional Venture PartnersHolder: Private Equity HoldersINT230-6#Intensity Therapeutics#INTS#biotech#intratumoral cancer therapy#NASDAQ